Altabor (dry tannic acid) – 20 mg.
ALTABOR has potent antiviral properties and is active against influenza viruses. The mechanism of antiviral action of ALTABOR is the induction of interferon synthesis while inhibiting influenza virus neuraminidase and herpesvirus thymidine kinase, which leads to the inhibition of viral DNA synthesis. ALTABOR has a broad-spectrum antibacterial action against gram-positive (Staphylococcus aureus, Bacillus subtilis) and gram-negative (Escherichia coli, Pseudomonas aeruginosa, Proteus mirabilis, Klebsiella) microorganisms. The pronounced antioxidant, anti-inflammatory, membrane-stabilizing, and analgesic effects potentiate pharmacotherapeutic action of this product in the treatment of acute respiratory viral infections and influenza, which are frequently complicated by bacterial infection and accompanied by pain and inflammation. ALTABOR tablets are orodispersible tablets, they are designed to be dissolved in the mouth rather than swallowed.
- used for the prevention and treatment of influenza and acute respiratory viral infections.
Dosage and pharmaceutical form:
tablets 20 mg, 10 tablets in blister; 10 tablets in blister, 2 blisters in package; 20 or 60 tablets in plastic container with tamper-evident cap.